[TLX] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Mar-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 28.07%
YoY- -122.17%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/12/18 30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 CAGR
Revenue 1,818 195 49 49 49 0 0 -
PBT -17,125 -10,524 -5,190 -3,928 -4,806 -1,571 -1,594 187.35%
Tax -6,756 1,884 -471 -471 -471 -38 -38 900.60%
NP -10,370 -8,640 -5,190 -3,457 -4,806 -1,571 -1,556 132.39%
Tax Rate - - - - - - - -
Total Cost 12,187 8,835 5,239 3,506 4,854 1,571 1,556 149.69%
Ratio Analysis
30/06/19 31/12/18 30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 CAGR
NP Margin -570.54 -4,430.77 -10,638.53 -7,087.06 -9,850.62 0.00 0.00 -
Per Share
30/06/19 31/12/18 30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 CAGR
EPS -0.05 -0.04 -0.03 -0.02 -0.02 -0.64 -0.01 104.52%
EPS Diluted -0.05 -0.04 -0.03 -0.02 -0.02 -0.64 -0.01 104.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.